Lung Cancer Screening Prevalence and Changes in 2024 - Takeaways - MDSpire

Lung Cancer Screening Prevalence and Changes in 2024

  • By

  • Todd Burus

  • Caree R. McAfee

  • Jennifer Redmond Knight

  • Timothy W. Mullett

  • Pamela C. Hull

  • June 1, 2026

  • 0 min

Share

  • 1

    The USPSTF recommends annual lung cancer screening for high-risk individuals aged 50 to 80 years to reduce morbidity and mortality.

  • 2

    In 2024, 24.49% of eligible respondents were up-to-date on lung cancer screenings, reflecting a 6% increase since 2022.

  • 3

    UTD screening prevalence varied by insurance type, with military-related coverage showing significantly higher rates than private insurance.

  • 4

    State-level UTD prevalence in 2024 ranged from 13.43% in South Dakota to 38.36% in Massachusetts, with significant increases in 21 states since 2022.

  • 5

    Despite overall improvements, no change in screening prevalence was observed among Hispanic, non-Hispanic Asian, or non-Hispanic Black adults.

Original Source(s)

Lung Cancer Screening Prevalence and Changes in 2024

  • by Todd Burus, Caree R. McAfee, Jennifer Redmond Knight, Timothy W. Mullett, Pamela C. Hull

  • June 1, 2026

Related Content

Risk prediction models for venous thromboembolism in lung cancer patients after surgery: a systematic review and meta-analysis

County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care

Exercise interventions for depressive symptoms in adults with lung and digestive cancer: a meta-analysis of randomized controlled trials